ABSTRACT Rabbit antiserum monospecific for an internal structural protein, p27, of avian sacroma viruses (ASV) was found to immunoprecipitate polypeptides with molecular weights (M,) of 180 000 and 76,000 from cell-free reticulocyte lysates programmed by ASV 35S RNA and also from lysates of ASV-infected cells. In addition, the Mr 180,000 protein was also precipitated by antiserum raised against virion DNA polymerase, suggesting that it is a product of translation of the two genes nearest the 5' end of virion 35S RNA.
ASV-infected cells. In addition, the Mr 180,000 protein was also precipitated by antiserum raised against virion DNA polymerase, suggesting that it is a product of translation of the two genes nearest the 5' end of virion 35S RNA.
We have also investigated the ability of subgenomic portions of virion RNA to program cell-free protein synthesis. A 10-12S poly(Acontaining fragment of RNA from both nondefective and transformation-efective ASV directed the synthesis of a polypeptide of Mr 29,000 immunologically unrelated to the gs antigens; 20-24S poly(A)containing RNA from nondefective ASV directed the synthesis of a polypeptide of Mr 60,000 not found when a similar RNA preparation from transformationdefective ASV was translated, suggesting that it is the product of the ASV src gene. These results indicate that internal initiation sites for protein synthesis exist on the 35S RNA genome. Avian sarcoma viruses (ASV) have been shown to contain at least four genetic elements: a gene for the internal structural proteins, gag; a gene for a viral DNA polymerase, p0o; a gene for the viral envelope glycoprotein, env; and a gene for a protein that causes cell transformation, src. The order of these genes on the viral RNA is 5'-gag-pol-env-src-poly(A)-3' (1) . Although the viral genome is 35 S. virus-specific RNAs of several sizes are found in RNA tumor virus-transformed cells. One has the same size and polarity as the viral genome whereas others consist of discrete subgenomic portions of the 35S RNA (2, 3) . If subgenomic RNA does serve as messenger for virus-specific proteins in infected cells, 35S RNA may contain internal initiation sites for protein synthesis.
Intact virion 35S RNA has been reported to program the synthesis of a polypeptide of molecular weight (Mr) 76,000 in cell-free extracts (4) (5) (6) . According to studies carried out in vivo, a polypeptide of Mr 76,000 (Pr76) yields the mature internal structural proteins of the virus (7) . Because the gag gene has been located at the 5' end of the ASV genome and several thousand molecules of the gag product are found in each virion whereas only a few hundred molecules of other virion proteins are present (8) , some mechanism exists to regulate the synthesis of viral structural proteins. For example, perhaps there is a single initiation site at the 5' end that is functional on 35S RNA and serves as message for the internal structural proteins whereas subgenomic RNA molecules may serve as message for other virus-specific proteins. Such a scenario would help explain the different molar ratios of virion-polypeptides produced in infected cells.
In the experiments reported here, we reinvestigated the 35S
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RNA molecule as a message in cell-free extracts and tested the messenger activity of subgenomic 3' ends of virion RNA.
MATERIALS AND METHODS Preparation of Viral RNA. Rous sarcoma virus, nondefective (nd) and transformation defective (td) Prague .strain of ASV subgroup C (PrC), was harvested at 8-to 18-hr intervals from the supernatant medium of infected chick embryo fibroblasts (Spafas, Inc., Roanoke, IL) and purified, and 35S RNA was prepared as described (9) . Subgenomic fragments were recovered from the same sucrose gradient used to purify 35S RNA, and poly(A)-containing RNA was isolated from these fragments as follows. RNA was precipitated twice with ethanol, dissolved in 0.01 M Tris-HCI, pH 7.4/0.2% sodium dodecyl sulfate (NaDodSO4), and heated to 800 for 3 min. The solution was then quick-chilled, adjusted to 0.5 M NaCI/0.5% NaDodSO4/0.01 M Tris-HCl, pH (Fig. 1) . One polypeptide of Mr 45,000 was synthesized in the unprogrammed lysate as shown in Fig. 1 (track 1) . The specificity of translation could be monitored with monospecific antiserum raised against the ASV protein p27. As shown in Fig. 2 The identity of A was further investigated by immunoprecipitation with antiserum raised against virion DNA polymerase. When anti-DNA polymerase IgG was used to precipitate in vitro polypeptide products, some Pr76 was usually present in the precipitate in addition to A, but A could be specifically immunoprecipitated from lysates of infected cells with anti-polymerase IgG (Fig. 4) blocked with purified DNA polymerase (Fig. 4, track 7 ) but DNA polymerase had no effect on the immunoprecipitation of A by anti-p27 serum (Fig. 4, track 8) . Therefore, the polypeptide of Mr 180,000 appeared to contain antigenic determinants for both p27 and DNA polymerase. One Fig.  5 , regions from the 3' end of virion RNA did not program the synthesis of Pr76 in cell-free extracts but resulted in the synthesis of discrete polypeptides that were not immunoprecipitated by anti-p27 serum (data not shown). Both nd and td 10-12S RNA, which were apparently derived from heteropolymeric RNA sequences common to both nd and td virion RNA (16, 17) , programmed the synthesis of a doublet with a Mr of 29,000 (Fig. 5, tracks 6 and 7) .
The results found upon translation of 20-24SRNA were different, however. The nd RNA programmed the synthesis of a large amount of polypeptide of Mr 60,000 absent from the translation products of td 20-24S RNA. In both the nd and td translation products, a polypeptide of Mr 64,000 was found (Fig. 5, tracks 4 and 5) . The polypeptide of Mr 60,000 could not be immunoprecipitated by antibody directed against virion components and, because it was absent from the translation products of td RNA that contains a deletion in the src gene, it may be the polypeptide encoded by the src gene of nd ASV. A large amount of virus was required to prepare nd RNA fragments, and consequently this RNA no doubt contained some RNA from deletion mutants which arise spontaneously during growth of nd virus (18, 19) and which may result in the two polypeptides (Mr 60,000 and 64,000) in Fig. 5, track of the ribosomes terminate synthesis with generation of Pr76 but a small number continue and translate the pol gene as well. The resultant polypeptide of Mr 180,000 could be cleaved by a protease in the infected cell to yield a functional polymerase and additional Pr76. This result suggests a mechanism for the generation of unequal amounts of polymerase and internal structural proteins and circumvents the need for a mRNA for polymerase in the infected cell. Support for this conclusion has also been obtained in studies with murine oncornavirus (5, 20, 21) .
We believe that the translation of the subgenomic regions of the ASV genome selected here is a valid'approach for several reasons. These RNA species probably lack 5'-terminal 7-methylguanosine because they are derived by nuclease clevage of 35S RNA; however, recent results illustrate that RNA lacking a 5'-terminal 7-methylguanosine is correctly translated in reticulocyte lysates (22) although this terminus may be required in other cell-free extracts (23) . N-Formylmethionine from N-formyl-[-35S]methionyl-tRNA et, which donates methionine at the NH2 terminus of proteins, is incorporated into the major polypeptides shown in Fig. 5 (A. Siddiqui and A. F. Purchio, unpublished data), indicating that correct initiation has occurred. The 3' one-third of the ASV genome is expressed in transformed cells as virus-specific 21S mRNA (3). Furthermore, there is precedent for internal sites for the initiation of protein synthesis based on the genome of another virus (24) . Throughout the course of this work, we have assumed that no significant amount of cellular mRNA is present in the 70S RNA prepared from virions, but that possibility is now being tested.
The 20-24S RNA from nd virus selected and translated in these studies is illustrated under 21S in Fig. 6 . Our results demonstrate that nd 21S RNA programs the synthesis of a polypeptide with a Mr of 60,000 not programmed by a similar preparation of td RNA. Moreover, evidence has recently been obtained for a transformation-specific antigen of Mr 60,000 in ASV-transformed cells (25) . Experiments to prove whether this polypeptide is the product of the src gene are required. It is clear from the map of 35S RNA that 21S poly(A)-containing RNA from td virus which has a deletion of the src gene may contain the env gene and we believe that translation of this gene produces the polypeptide of Mr 64,000 seen in Fig. 5 , a provisional conclusion that requires additional evidence. We have preliminary evidence with virion 20-24S poly(A)-containing RNA from RAV-2, which is a nontransforming virus, that this polypeptide is antigenically related to the glycoprotein found in the envelope of the virus. This result is consistent with the experiments of Stacey et al. (26) which demonstrated that 20-24S RNA from RAV-2-infected cells encodes the viral glycoprotein.
Finally, it must be noted that 3-terminal heteropolymeric RNA sequences found in both nd and td viruses can program the synthesis of a polypeptide of Mr 29,000, which appears as a doublet in Fig. 5 . No protein essential for the replication of ASV has been identified as encoded by this region of the genome; however, it is possible that this polypeptide functions in a way not easily defined genetically or biochemically. Kamine and Buchanan (27) reported that 35S RNA from nd virus programs the cell-free synthesis of polypeptides in this size range that are not found when td RNA is used. Our results are inconsistent with this claim because we find that the only polypeptide uniquely produced by RNA from transforming virus has a Mr of 60,000. Because the strategy used here is completely different from the one they used, additional experiments are required to resolve this apparent discrepancy.
Whether or not a specific polypeptide product can be assigned to a specific ASV gene at this time, we feel that the approach outlined in this communication illustrates the usefulness of subgenomic regions of ASV virion RNA in cell-free translation experiments and may provide a means to study the polypeptides encoded by specific ASV genes.
